NCT03950479

Brief Summary

Injuries to the pelvic floor muscles and fascias during delivery and childbirth may lead to urinary incontinence (25-45 %), faecal incontinence (11-45%), pelvic organ prolapse (7-23%), sexual dysfunction (15-33 %) and chronic pain syndromes (4-15%). Pelvic floor muscle injuries are not easy to diagnose as they are not visible when looking at surface anatomy during a standard gynaecological examination. The investigators are therefore in urgent need of better tools to diagnose these injuries. Having a reliable and easily accessible tool enables studies of the consequences of such pelvic floor muscle injuries. It also makes it possible for us to explore the effect of interventions such as pelvic floor muscle training and surgery in patients with and without pelvic floor muscle injuries. The investigators have previously presented data to support the reliability and the validity of the three and four dimensional (3 and 4D) ultrasound technique used to define pelvic floor muscle anatomy in healthy volunteers and have now a tool to study women before and after delivery.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2019

Longer than P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 11, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 15, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

June 15, 2019

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2024

Completed
Last Updated

May 15, 2019

Status Verified

May 1, 2019

Enrollment Period

5 years

First QC Date

May 11, 2019

Last Update Submit

May 11, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Levator Hiatus Area at Rest Measured Via 3-dimensional transperineal Ultrasound at Gestational Week 24 and 37

    3-dimensional ultrasound was used to capture the axial plane of the pelvic floor in order to measure LH area. Levator hiatus area was measured at gestational week 24 and 37, at rest, during contraction and during Valsalva maneuver - giving 6 measurements all together. The change in LH area was computed between the two different timepoints giving 3 outcomes

    24 weeks and 37 weeks of gestation

Secondary Outcomes (2)

  • Change in Levator Hiatus Area at Contraction Measured Via 3D transperineal Ultrasound at Gestational Week 24 and 37

    24 weeks and 37 weeks of gestation

  • Change in Levator Hiatus Area During Valsalva Maneuver Measured Via 3D transperineal Ultrasound

    gestational week 24 and 37

Study Arms (1)

primiparous group

women who will give birth to their first baby

Diagnostic Test: 3D and 4D Transperineal Ultrasound

Interventions

The evaluation of Pelvic Floor Muscles with 3D and 4D transperineal ultrasound using A Voluson E6 system (GE Healthcare, Zipf, Austria) with RAB 8-4-MHz volume transducer for all acquisitions. Measurements will be performed in axial planes. The levator hiatus area (LHA), the antero-posterior (AP) diameter and the left-right (LR) transverse diameter will be analyzed at rest, during pelvic floor contraction and on maximal Valsalva maneuver.

primiparous group

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women giving birth to their first child at Cairo University Hospital, Egypt and University Hospital Würzburg, Germany.

You may qualify if:

  • Women giving birth to their first child at Cairo University Hospital, Egypt and University Hospital Würzburg, Germany.

You may not qualify if:

  • Previous pregnancy of more than 16 weeks.
  • preterm delivery less than 32 weeks gestation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pelvic Floor Disorders

Condition Hierarchy (Ancestors)

Female Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPregnancy ComplicationsMale Urogenital Diseases

Study Officials

  • AHMED SAMY, MD

    Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor of obstetrics and gynecology

Study Record Dates

First Submitted

May 11, 2019

First Posted

May 15, 2019

Study Start

June 15, 2019

Primary Completion

June 1, 2024

Study Completion

October 15, 2024

Last Updated

May 15, 2019

Record last verified: 2019-05